Law firm Fenwick & West, which handles legal issues for a variety of technology companies, has examined 186 venture fundings of U.S.-based companies in the life-sciences sector over the first half of 2012, and found that valuations have ticked upward.
Matt Rossiter, a partner at the firm and co-author of a recent survey on life-sciences deals, said he has also noticed increased involvement in deals by public medical-technology companies, who often turn to start-ups for new innovations.
{iframe}http://blogs.wsj.com/venturecapital/2012/09/11/u-s-life-sciences-valuations-creeping-upward-law-firm-says/?mod=WSJBlog{/iframe}